// startup autopsy
Pharmacopeia
Combinatorial chemistry pioneer absorbed into a larger pipeline
marketfitAcqui-hire
Fatal mistake: Built a strong combinatorial chemistry platform but could not convert its technology into proprietary drugs capable of sustaining standalone company value.
Key Events Timeline
FOUNDING
Pharmacopeia founded in the USA to develop combinatorial chemistry and drug discovery platforms.
PRODUCT LAUNCH
Pharmacopeia launched its high-throughput combinatorial chemistry platform, attracting major pharma partnerships.
FUNDING
Last known funding round secured, bringing total to $7.63M as the company sought to advance its pipeline.
PIVOT
Pharmacopeia shifted focus toward licensing its compound libraries and discovery tools as internal drug development stalled.
SHUTDOWN
Ligand Pharmaceuticals acquired Pharmacopeia, ending its independent existence after 16 years.